Marianne Jacob
Pediatric Endocrinology · West Orange, NJNPI 1215453857
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations.
Across 145 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$342
- Novo Nordisk$187
- Dexcom, Inc.$186
- AstraZeneca$140
- Sanofi-aventis U.S. LLC$139
- Ascendis Pharma Endocrinology Inc$134
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,506100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $342 |
| Novo Nordisk | 12 | $187 |
| Dexcom, Inc. | 5 | $186 |
| AstraZeneca | 7 | $140 |
| Sanofi-aventis U.S. LLC | 8 | $139 |
| Ascendis Pharma Endocrinology Inc | 8 | $134 |
| Pfizer | 7 | $130 |
| Azurity Pharmaceuticals, Inc. | 7 | $116 |
| Tolmar, Inc. | 7 | $108 |
| Tandem Diabetes Care, Inc. | 4 | $103 |
| Medtronic | 5 | $103 |
| Endo Pharmaceuticals Inc. | 5 | $70 |
| Kyowa Kirin, Inc. | 4 | $70 |
| Rhythm Pharmaceuticals, Inc. | 4 | $68 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| Biomarin Pharmaceutical Inc. | 4 | $62 |
| Insulet Corporation | 3 | $55 |
| Neurocrine Biosciences, Inc. | 3 | $52 |
| Endo USA, Inc. | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 3 | $44 |
| Lilly USA, LLC | 3 | $42 |
| Ultragenyx Pharmaceutical Inc. | 2 | $36 |
| Johnson & Johnson | 2 | $34 |
| Soleno Therapeutics, Inc. | 1 | $32 |
| Amphastar Pharmaceuticals, Inc. | 1 | $15 |
| Mylan Institutional Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Tolmar Pharmaceuticals, Inc. | 1 | $15 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $14 |
| IBSA Pharma Inc. | 1 | $14 |
| Mylan Specialty L.p. | 1 | $14 |
| Sandoz | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Eton Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,506 in reported general payments places this provider in the 70th percentile of 59 pediatric endocrinology providers in New Jersey.
Other pediatric endocrinology in West Orange
- Dennis BrennerWest Orange$39K
- Irene MamkinWest Orange$13K
- Lawrence SilvermanMorristown$492K
- Ahmed KhattabNew Brunswick$70K
- Ian MarshallNew Brunswick$51K
- Eric HuangBasking Ridge$23K
- Elizabeth BurtmanTenafly$10K
- Javier AisenbergHackensack$10K
- Hope-Elizabeth ClennonNewark$8K
- Glenn GormleyBrick$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.